This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

Investor Releases

Date Title View
30 June, 2016 ICON to Acquire Clinical Research Management, Inc.
23 June, 2016 ICON: DIA Live to Provide a Digital Window into DIA Conference 2016
15 June, 2016 New Research from ICON Demonstrates Support for ‘Bring Your Own Device' Approach in Clinical Trials
10 June, 2016 ICON Announces Service Agreement with Pfizer
16 May, 2016 ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research Excellence Awards
26 April, 2016 ICON Reports First Quarter 2016 Results
29 March, 2016 Mr. Thomas Lynch Notifies ICON of His Retirement as Chairman and That He Will Not Stand for Re-Election to the Board of Directors at the Annual General Meeting
08 March, 2016 ICON Selected by the International Consortium for Health Outcomes Measurement to Help Advance Value-based Healthcare
23 February, 2016 ICON Reports Fourth Quarter and Full Year 2015 Results and Issues 2016 Earnings Guidance
09 February, 2016 ICON selected by Genomics England to support the largest genome sequencing project of its kind for cancer and rare diseases
05 January, 2016 ICON Secures Investment Grade Credit Ratings
16 December, 2015 ICON plc Announces Private Placement of US$350,000,000 of Senior Notes
07 December, 2015 ICON Acquires PMG Research, Inc.
25 November, 2015 ICON Announces the Appointment of Dr. Steve Cutler to Board of Directors
27 October, 2015 ICON Reports Third Quarter 2015
10 September, 2015 ICON and IBM to Revolutionise Clinical Trial Feasibility, Patient Recruitment and Study Start-up Timelines
28 July, 2015 ICON Reports Second Quarter 2015
27 July, 2015 ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
17 June, 2015 ICON Launches Firecrest Patient Portal to Enhance Education around Informed Consent
28 April, 2015 ICON Reports First Quarter 2015
Displaying 101 - 120 of 327

Search Investor